Evidence map›Paper›PMID 16435202›Full record

ArticleJournal of inherited metabolic disease2005

Mutation detection in four candidate genes (OXA1L, MRS2L, YME1L and MIPEP) for combined deficiencies in the oxidative phosphorylation system.

M J H Coenen, J A M Smeitink, R Smeets, F J M Trijbels, L P van den Heuvel

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Case report: Rare novelFrontiers in cardiovascular medicine · 2022
    Article
  3. Article
  4. EMBO molecular medicine · 2018
    Article
  5. Building the CuThe Journal of biological chemistry · 2018
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M J H CoenenNijmegen Centre for Mitochondrial Disorders, Department of Paediatrics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
J A M Smeitink
R Smeets
F J M Trijbels
L P van den Heuvel
Radboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria are the main energy-producing organelles of the cell. Five complexes embedded in the mitochondrial inner membrane, together constituting the oxidative phosphorylation (OXPHOS) system, comprise the final steps in cellular energy production. Many patients with a mitochondrial defect suffer from a so-called combined deficiency, meaning that the enzymatic activities of two or more complexes of the OXPHOS system are decreased. Numerous mutations have been described in nuclear genes that are involved in the functioning of a single complex of the OXPHOS system. However, little attention has been paid to patients with a deficiency of more than one complex of this particular system. In this study we have investigated four nuclear genes (OXA1L, MRS2L, YME1L and MIPEP) that might be involved in the pathology of combined enzymatic deficiencies of the OXPHOS system. Based on the results of yeast knockouts of these four proteins, we have sequenced the open reading frame of OXA1L in eight patients with an enzymatic deficiency of complexes I and IV. MRS2L, YME1L and MIPEP have been sequenced in three patients with a combined defect of complexes III and IV. No mutations were detected in these patients, showing that at least in these patients the OXPHOS system deficiency cannot be explained by a mutation in these four genes.

Indexed as

DNA Mutational AnalysisATPases Associated with Diverse Cellular ActivitiesCation Transport ProteinsCell NucleusDNA, ComplementaryElectron Transport Complex IVExpressed Sequence TagsFibroblastsHeterozygoteHumansMetalloendopeptidasesMitochondrial DiseasesMitochondrial ProteinsMutationNuclear ProteinsOpen Reading FramesATPases Associated with Diverse Cellular ActivitiesCation Transport ProteinsDNA, ComplementaryElectron Transport Complex IVMetalloendopeptidasesmitochondrial intermediate peptidaseMitochondrial ProteinsMRS2 protein, humanNuclear ProteinsOXA1 proteinOxygenYME1L1 protein, human

Identifiers

PMID16435202
OpenAlexW1987703509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.